Global Pathogen Discovery Lab

About

The Global Pathogens Discovery Laboratory works collaboratively on projects that need microbiology surveillance, identification and discovery. The laboratory was created in response to the need for high quality molecular and culture-based assays to detect, identify, and quantify pathogens, with a particular emphasis on analysis of environmental and animal samples. The founding director, Dr. John Lednicky, has more than 20 years of academic research and industry experience in developing assays to quantify pathogens and identify unknown viruses in environmental, wildlife, and human samples. In response to the current COVID-19 pandemic, we have developed an in-house rtRT-PCR-based assay to detect SARS-CoV-2 in water, air, and human specimens for research purposes. The Laboratory has dedicated BSL2 space and access to BSL3 suites.

Recent News

Dr. Ilaria Capua published in The Lancet: “The…

The current vaccination campaign against SARS-CoV-2 has many challenging aspects, one of which is maintaining the cold chain for the distribution…

capua

“Coronavirus hit Florida earlier than we thought…

Published Feb. 11 Around this time last year, a group of researchers at the University of Florida began their annual search for flu…

stephenson

Coronavirus 2019 Infectious Disease Epidemic…

See Dr. Lednicky’s recent publication in the Journal of Thoracic Oncology, “Coronavirus 2019 Infectious Disease Epidemic: Where We Are, What Can Be…

testinglabpic